PRIME MEMBER EXCLUSIVE | 3 Months Free Trial
Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.
#61. AI Era Evidence Flywheel
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
In this episode, Dr. Jake Chen provides his narrative review and advocates for a fundamental shift in pharmaceutical research, moving away from inefficient trial-and-error toward an AI-augmented scientific discipline. The text outlines 12 core principles to transform drug discovery into a mechanism-aware system that prioritizes causal target biology, early safety prediction, and patient-centered strategies. Instead of using artificial intelligence simply to increase speed, Chen argues that these tools should reduce uncertainty and help researchers respect the fundamental laws of biology and chemistry. The source provides a comprehensive operational framework, including a decision-centric "evidence flywheel" and specific governance checklists for ensuring regulatory-grade credibility. Ultimately, the author suggests that the industry's future depends on human-AI collaboration, in which technology enhances rather than replaces rigorous scientific judgment. Produced by Dr. Jake Chen.